MORGAN STANLEY RESEARCH Morgan Stanley & Co. MARCH 24, 2010 NorthNorth HIGHLIGHTS AmericaAmerica 23 Healthcare Svcs. & Distribution INVESTMENT Upgrade MCK on Growth Prospects; Downgrade DGX, LH PERSPECTIVES on Lack of Catalysts Ricky R. Goldwasser et al.
39 o Menthol: FDA Advisory Panel Likely to Focus on Soft Issues, Not Relative Risk David J. Adelman et al.
43 Coach We’re Buyers of COH Heading into 3Q Results April 20
Michelle L. Clark et al.
Strategy and Economics 19 Currency Strategy Currency Politics Heating Up Sophia Drossos 3 Morgan Stanley Best Ideas List 21 mentary Behind the Spreadsheet: 7 US Economics The Rebirth of Pricing Power The Handset Wars (Simon Flannery/Ehud Richard Berner Gelblum/Katy Huberty/Mary Meeker), Part I 9 US Credit Strategy Performance BBooster Douglas M. Cohen Rizwan Hussain, Adam Richmond, Jocelyn Chu Opinion Changes 11 Global Equity Strategy Permanently Higher Plateau? 23 Healthcare Services & Distribution Gerard Minack, Jason Todd MCK Upgraded on Growth Prospects; DGX and LH Downgraded on Lack of Catalysts 13 UK Equity Strategy Ricky R. Goldwasser, Hema Srinivasan, Andrew Schenker Why EM Trade Has Further to Run Graham Secker, Catharina Luebke-Detring New Coverage 15 China Equity Strategy A Revisit to Rmb 25 Freight Transportation Revaluation’s Market Implications Freight Forwarders: Too Early To Go Late Cycle; Jerry Lou, Allen Gui We Prefer UTIW to EXPD 17 Equity Derivative Strategy The Short Volatility William J. Greene, Adam Longson Trade – From Cyclical to Carry (continued) Sivan Mahadevan, Christopher Metli et al.
Morgan Stanley does and seeks to do business panies covered in its research reports. As a result, investors should be aware that the firm may have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only a single